Type
Internal restructuring
Country
Netherlands
Region
Location of affected unit(s)
Arnhem, Oss
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

100 jobs
Number of planned job losses
Job loss
Announcement Date
20 February 2004
Employment effect (start)
1 February 2004
Foreseen end date
1 December 2004

Description

To face the declining demand, Diosynth is reducing its worldwide chemical synthesis capacity by scaling back facilities in the Netherlands, closing its site in Mexico and reducing the production capacity at Buckhaven (Scotland) site. The workforce in the Netherlands will be reduced by 100 employees in the course of 2004 through natural attrition and expiry of the majority of temporary employment contracts. Consultation involving unions and works councils will be undertaken.


Sources

  • 20 February 2004: Akzo Nobel - Press releases (www.akzonobel.com)
  • 20 February 2004: Het Financieele Dagblad

Citation

Eurofound (2004), Akzo Nobel, Internal restructuring in Netherlands, factsheet number 60051, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/60051.